다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

CELG

Celgene (CELG)

Celgene Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CELG

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2019/12/16	21:30	GlobeNewswire Inc.	NexImmune Appoints Sol Barer as Chairman of the Board of Directors	NASDAQ:CELG	Celgene Corporation
2019/11/21	20:21	PR Newswire (US)	Amgen Completes Acquisition Of Otezla® (apremilast)	NASDAQ:CELG	Celgene Corporation
2019/11/21	06:18	Business Wire	Celgene Announces Plans to Transfer Listing of Celgene’s Contingent Value Rights Following Closing of Acquisition by Bristo...	NASDAQ:CELG	Celgene Corporation
2019/11/21	04:09	Business Wire	CELGENE ERHÄLT DIE ZULASSUNGSEMPFEHLUNG DES CHMP FÜR LENALIDOMID (REVLIMID®) IN KOMBINATION MIT RITUXIMAB ZUR BEHANDLUNG V...	NASDAQ:CELG	Celgene Corporation
2019/11/20	01:16	PR Newswire (US)	Thermo Fisher Scientific Set to Join S&P 100; ServiceNow to Join S&P 500	NASDAQ:CELG	Celgene Corporation
2019/11/19	07:10	GlobeNewswire Inc.	Exelon Corporation to Join the NASDAQ-100 Index Beginning November 21, 2019	NASDAQ:CELG	Celgene Corporation
2019/11/16	07:39	Dow Jones News	FTC Requires Bristol-Meyers Squibb, Celgene to Divest Otezla as Condition of Acquisition	NASDAQ:CELG	Celgene Corporation
2019/11/15	22:22	Dow Jones News	Celgene Gets CHMP Positive Opinion for Revlimid/Rituximab Combo in Follicular Lymphoma	NASDAQ:CELG	Celgene Corporation
2019/11/15	21:30	Business Wire	Celgene Receives CHMP Positive Opinion for REVLIMID® (lenalidomide) in Combination With Rituximab for the Treatment of Adult...	NASDAQ:CELG	Celgene Corporation
2019/11/13	12:28	PR Newswire (Canada)	Skyhawk Therapeutics annonce une deuxième entente de collaboration multicible avec Celgene pour découvrir et mettre au poin...	NASDAQ:CELG	Celgene Corporation
2019/11/12	23:00	PR Newswire (US)	Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...	NASDAQ:CELG	Celgene Corporation
2019/11/12	23:00	PR Newswire (Canada)	Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...	NASDAQ:CELG	Celgene Corporation
2019/11/09	03:30	Dow Jones News	Acceleron Pharma Shares Gain Ground After FDA Approves Reblozyl	NASDAQ:CELG	Celgene Corporation
2019/11/09	03:20	Dow Jones News	FDA Approves Celgene's and Acceleron's Reblozyl to Treat Rare Blood Disorder	NASDAQ:CELG	Celgene Corporation
2019/11/09	02:33	Business Wire	FDA Approves REBLOZYL® (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular R...	NASDAQ:CELG	Celgene Corporation
2019/11/07	06:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
2019/11/06	23:06	Business Wire	Celgene to Present New & Updated Data on Key Hematology Pipeline Therapies at American Society of Hematology (ASH) 2019 Annua...	NASDAQ:CELG	Celgene Corporation
2019/11/05	06:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
2019/11/05	06:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
2019/11/05	06:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
2019/11/05	06:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
2019/11/05	06:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
2019/11/01	05:05	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CELG	Celgene Corporation
2019/10/31	20:37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELG	Celgene Corporation
2019/10/31	20:30	Business Wire	Celgene Reports Third Quarter 2019 Operating and Financial Results	NASDAQ:CELG	Celgene Corporation
2019/10/16	19:00	Business Wire	Celgene & the Multiple Sclerosis Association of America Take the MS MindShift Initiative & “Brain Bulb” Hot Air Balloon t...	NASDAQ:CELG	Celgene Corporation
2019/09/20	20:30	Business Wire	Celgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant Recipients	NASDAQ:CELG	Celgene Corporation
2019/09/20	05:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
2019/09/13	05:30	Business Wire	Celgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myel...	NASDAQ:CELG	Celgene Corporation
2019/09/12	01:24	Dow Jones News	Swiss Biotech Anokion Raises $40 Million in Series B Round	NASDAQ:CELG	Celgene Corporation

검색 관련기사 보기:NASDAQ:CELG

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Sterling

Verizon Communications

JP Morgan Chase

Invesco QQQ Trust Series 1

American Express

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관